INSTITUTE OF BIOMEDICINE AND MOLECULAR GENETICS (IBGM)
Institute
University of Turin
Turín, ItaliaPublications in collaboration with researchers from University of Turin (11)
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2015
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
2012
2011
-
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Breast Cancer Research, Vol. 13, Núm. 6
-
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116
-
Nimodipine inhibits AP firing in cultured hippocampal neurons predominantly due to block of voltage-dependent potassium channels
General Physiology and Biophysics, Vol. 30, Núm. SPECIAL
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754
2004
-
WIP Regulates Signaling via the High Affinity Receptor for Immunoglobulin E in Mast Cells
Journal of Experimental Medicine, Vol. 199, Núm. 3, pp. 357-368
2002
-
RET activation and clinicopathologic features in poorly differentiated thyroid tumors
Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 1, pp. 370-379